Clinical use of a combined-action antihypertensive medication urapidil

Abstract

Currently, combined antihypertensive therapy is considered as the leading strategy in the management of patients with arterial hypertension. One of the effective combined antihypertensive medications is a hybrid agent urapidil, which chemical structure provides a combination of central antihypertensive action and peripheral vasodilatation. This review discusses the results of the clinical and experimental studies on urapidil antihypertensive effectiveness. The clinical use of the medication, as well as its good tolerability and safety, is also discussed.

Keywords

• arterial hypertension
• antihypertensive therapy
• hypertensive crise
• urapidil